Authors' objectives:

This study aims to assess the current evidence on endoluminal gastroplication for gastro-oesophageal reflux disease.

Authors' recommendations: 1.1 Current evidence suggests that there are no major safety concerns associated with endoluminal gastroplication for gastro-oesophageal reflux disease (GORD). However, evidence of efficacy is not adequate for this procedure to be used without special arrangements for consent and for audit or research. 1.2 Clinicians wishing to undertake endoluminal gastroplication for GORD should take the following actions. - Inform the clinical governance leads in their Trusts. - Ensure that patients understand the uncertainty about the procedures efficacy and provide them with clear written information. Use of the Institute's Information for the public is recommended. - Audit and review clinical outcomes of all patients having endoluminal gastroplication for GORD. 1.3 Publication of efficacy outcomes will be useful in reducing the current uncertainty. The Institute may review the procedure upon publication of further evidence.

Authors' methods: Overview

Project Status: Completed

URL for project: http://www.nice.org.uk/ipcat.aspx?c=212198

Year Published: 2005

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: England, United Kingdom

Organisation Name: National Institute for Clinical Excellence

Contact Address: MidCity Place, 71 High Holborn, London WC1V 6NA, UK. Tel: +44 020 7067 5800; Fax: +44 020 7067 5801

Contact Name: nice@nice.nhs.uk

Contact Email: nice@nice.nhs.uk

Copyright: National Institute for Clinical Excellence (NICE)